Ajanta Pharma Outperforms Sector Amid Broader Market Positivity and Mixed Long-Term Trends
Ajanta Pharma has gained 3.04% on July 3, 2025, outperforming its sector. The stock has risen consecutively over two days, reaching an intraday high of Rs 2630. While it shows mixed performance year-to-date, it has significantly increased over the past three and five years.
Ajanta Pharma has shown notable activity today, gaining 3.04% on July 3, 2025. This performance has allowed the stock to outperform its sector by 2.7%. Over the past two days, Ajanta Pharma has experienced a consecutive gain, rising a total of 4.62%. The stock reached an intraday high of Rs 2630, reflecting a 3.51% increase at its peak.In terms of moving averages, Ajanta Pharma's stock is currently above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average.
Looking at broader market trends, the Sensex opened positively, trading at 83,557.77, up 131.05 points or 0.18%. It is currently 2.9% away from its 52-week high of 85,978.25 and is trading above its 50-day moving average, which is also above the 200-day moving average.
Ajanta Pharma's performance metrics over various time frames indicate a mixed trend, with a year-to-date decline of 11.13% compared to the Sensex's gain of 6.94%. However, over the longer term, the stock has shown significant growth, with a 3-year increase of 107.02% and a 5-year increase of 181.09%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
